- Abstract:
-
BACKGROUND: Type I allergy represents a severe health problem in industrialized countries where up to 20% of the population suffer from allergic rhinitis, conjunctivitis and allergic asthma bronchiale and in severe cases from anaphylaxis, leading to death. OBJECTIVE: The aim of this study was to evaluate recombinant Bet v I, the major birch pollen allergen for in vivo and in vitro diagnosis of birch pollen allergy. METHODS: A group of 51 birch pollen allergic patients and eight non-allergic ...
Expand abstract - Publication status:
- Published
- Journal:
- Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
- Volume:
- 26
- Issue:
- 1
- Pages:
- 50-60
- Publication date:
- 1996-01-05
- DOI:
- EISSN:
-
1365-2222
- ISSN:
-
0954-7894
- URN:
-
uuid:f723a4a4-a504-424f-a0f8-3f0912153893
- Source identifiers:
-
69744
- Local pid:
- pubs:69744
- Language:
- English
- Keywords:
- Copyright date:
- 1996
Journal article
Serological and skin-test diagnosis of birch pollen allergy with recombinant Bet v I, the major birch pollen allergen.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record